Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
43
CRSP Quote, Financials, Valuation and Earnings
Last price:
$55.05
Seasonality move
:
9.38%
Day range:
$53.76 - $56.54
52-week range:
$30.04 - $78.48
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
125.63x
P/B ratio:
2.74x
Volume:
1.4M
Avg. volume:
2.1M
1-year change:
34.11%
Market cap:
$5.2B
Revenue:
$37.3M
EPS (TTM):
-$5.58
CRISPR Therapeutics AG SEC Filings
| Company | Filed | Form Type | Description | |
|---|---|---|---|---|
|
CRSP
CRISPR Therapeutics AG
|
11/06/2023 | 10-Q | 10-Q filing on 11/06/2023 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
08/07/2023 | 10-Q | 10-Q filing on 08/07/2023 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
05/08/2023 | 10-Q | 10-Q filing on 05/08/2023 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
11/01/2022 | 10-Q | 10-Q filing on 11/01/2022 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
08/08/2022 | 10-Q | 10-Q filing on 08/08/2022 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
05/09/2022 | 10-Q | 10-Q filing on 05/09/2022 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
11/03/2021 | 10-Q | 10-Q filing on 11/03/2021 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
07/29/2021 | 10-Q | 10-Q filing on 07/29/2021 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
04/27/2021 | 10-Q | 10-Q filing on 04/27/2021 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
02/16/2021 | 10-K | 10-K filing on 02/16/2021 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
10/28/2020 | 10-Q | 10-Q filing on 10/28/2020 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
07/27/2020 | 10-Q | 10-Q filing on 07/27/2020 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
04/28/2020 | 10-Q | 10-Q filing on 04/28/2020 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
02/12/2020 | 10-K | 10-K filing on 02/12/2020 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
10/28/2019 | 10-Q | 10-Q filing on 10/28/2019 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
07/29/2019 | 10-Q | 10-Q filing on 07/29/2019 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
04/29/2019 | 10-Q | 10-Q filing on 04/29/2019 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
02/25/2019 | 10-K | 10-K filing on 02/25/2019 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
11/07/2018 | 10-Q | 10-Q filing on 11/07/2018 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
08/07/2018 | 10-Q | 10-Q filing on 08/07/2018 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
05/08/2018 | 10-Q | 10-Q filing on 05/08/2018 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
03/08/2018 | 10-K | 10-K filing on 03/08/2018 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
11/08/2017 | 10-Q | 10-Q filing on 11/08/2017 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
08/10/2017 | 10-Q | 10-Q filing on 08/10/2017 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
05/11/2017 | 10-Q | 10-Q filing on 05/11/2017 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
03/10/2017 | 10-K | 10-K filing on 03/10/2017 | View Form |
|
CRSP
CRISPR Therapeutics AG
|
11/22/2016 | 10-Q | 10-Q filing on 11/22/2016 | View Form |
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
64
GLTO alert for Dec 27
Galecto, Inc. [GLTO] is up 16.92% over the past day.
Buy
80
TVTX alert for Dec 27
Travere Therapeutics, Inc. [TVTX] is down 1.54% over the past day.
Sell
11
CDNAF alert for Dec 27
Canadian Tire Corp. Ltd. [CDNAF] is down 10% over the past day.
